...
首页> 外文期刊>Trials >OPTimal IMAging strategy in patients suspected of non-traumatic pulmonary disease at the emergency department: chest X-ray or ultra-low-dose chest CT (OPTIMACT) trial—statistical analysis plan
【24h】

OPTimal IMAging strategy in patients suspected of non-traumatic pulmonary disease at the emergency department: chest X-ray or ultra-low-dose chest CT (OPTIMACT) trial—statistical analysis plan

机译:涉及急诊部患者患者的最佳成像策略:胸部X射线或超低剂量胸部CT(优选)试验统计分析计划

获取原文
           

摘要

BACKGROUND:A chest X-ray is a standard imaging procedure in the diagnostic work-up of patients suspected of having non-traumatic pulmonary disease. Compared to a chest X-ray, an ultra-low-dose (ULD) chest computed tomography (CT) scan provides substantially more detailed information on pulmonary conditions. To what extent this translates into an improvement in patient outcomes and health care efficiency is yet unknown. The OPTimal IMAging strategy in patients suspected of non-traumatic pulmonary disease at the emergency department: chest X-ray or ultra-low-dose chest CT (OPTIMACT) study is a multicenter, pragmatic, non-inferiority randomized controlled trial designed to evaluate replacement of chest X-ray by ULD chest CT in the diagnostic work-up of such patients, in terms of patient-related health outcomes and costs. During randomly assigned periods of 1 calendar month, either conventional chest X-ray or ULD chest CT scan was used as the imaging strategy. This paper presents in detail the statistical analysis plan of the OPTIMACT trial, developed prior to data analysis.METHODS/RESULTS:Functional health at 28?days is the primary clinical outcome. Functional health at 28?days is measured by the physical component summary scale of the Short Form (SF)-12 questionnaire version 1. Secondary outcomes are mental health (mental component summary scale of the SF-12), length of hospital stay, mortality within 28?days, quality-adjusted life year equivalent during the first 28?days (derived from the EuroQol five-dimension, five-level instrument), correct diagnoses at emergency department discharge as compared to the final post hoc diagnosis at day 28, number of patients in follow-up because of incidental findings on chest X-ray or ULD chest CT, and health care costs.CONCLUSIONS:After this pragmatic trial we will have precise estimates of the effectiveness of replacing chest X-ray with ULD chest CT in terms of patient-related health outcomes and costs.TRIAL REGISTRATION:Netherlands National Trial Register: NTR6163. Registered on 6 December 2016.
机译:背景:胸部X射线是疑似非创伤性肺疾病的患者的诊断处理中的标准成像程序。与胸部X射线相比,超低剂量(ULD)胸部计算断层扫描(CT)扫描提供了关于肺条件的基本更详细的信息。这在多大程度上转化为患者结果和医疗效率的改善尚不清楚。涉及急诊部件非创伤性肺病的患者的最佳成像策略:胸部X射线或超低剂量胸部CT(优选)研究是一种旨在评估更换的多中心,务实,非较低的随机对照试验在患者相关的健康结果和成本方面,ULD Chest CT在胸部X射线在这些患者的诊断处理中。在随机分配的1个日历月期间,使用传统的胸部X射线或ULD胸部CT扫描作为成像策略。本文详细介绍了在数据分析之前开发的优选试验的统计分析计划。方法/结果:28岁的功能健康是主要的临床结果。功能健康在28?天的情况下,通过简短形式的物理成分汇总规模来衡量(SF)-12问卷版本1.二次结果是心理健康(SF-12的精神组件摘要规模),住院时间长度,死亡率在28岁以下的时间内,质量调整的终身年度相当于前28个?天(来自欧元QOL五维,五层仪器),在第28天的最后诊断时正确诊断急诊部门诊断,随访中的患者数量是胸部X射线或ULD胸部CT的偶然发现,以及保健成本。结论:在这个务实的试验之后,我们将精确估计用ULD胸部CT更换胸部X射线的有效性就患者相关的健康结果和成本而言。注册:荷兰国家试验登记册:NTR6163。 2016年12月6日注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号